Filament Health Archives

Psychedelics News

Filament Health

Finance

24 Nov 2023

Filament Health Announces US$14.4 million Funding & Planned NASDAQ Listing

Filament Health has signed a non-binding term sheet for up to US$14.4 million in funding through a convertible note....

By Microdose NewsDesk

Industry

8 Aug 2023

Filament Health Announces FDA Approval of Two Clinical Trials

FDA has approved two clinical trials studying the effects of PEX010, Filament's botanical psilocybin drug candidate....

By Microdose NewsDesk

Breaking News

20 Jul 2023

Filament Health Heading to NASDAQ With SPAC Merger

The agreement would merge Filament with Jupiter Acquisition Corporation (NASDAQ: JAQC)...

By Microdose NewsDesk

Industry

16 Mar 2023

Filament Health Announces FDA Approval Of Phase II Clinical Trial

Filament Health Announces FDA Approval Of Phase II Clinical Trial Studying Psilocybin For Methamphetamine Use Disorder...

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Don’t Miss

11 Jul 2022

News You Might Have Missed: July 11th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Don’t Miss

5 Jul 2022

News You Might Have Missed: July 5th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Don’t Miss

19 Apr 2022

News You Might Have Missed: April 19th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news items to help you catch up and stay informed....

By Jason Najum

Industry

23 Mar 2022

Filament Health Granted Second Patent

Filament has developed innovative technology to extract and standardize stable doses of natural compounds from magic mushrooms....

By Microdose

Psychedelic Titans

27 Jul 2021

Psychedelic Titans with Benjamin Lightburn of Filament Health

This week's Psychedelic Titan is Benjamin Lightburn, CEO & Co-Founder of Filament Health, a natural psychedelic drug development company....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result